Portfolio company
Pulmonx
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company manufactures endobronchial valves used by healthcare professionals to treat patients with severe emphysema and chronic obstructive pulmonary disease.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ryme Medical
The company develops catheter-based therapies for patients with chronic obstructive pulmonary disease to improve airflow and reduce symptoms through targeted lung denervation.
AirNexis Therapeutics
This company develops inhaled small molecule medicines to treat chronic obstructive pulmonary disease for patients with respiratory conditions.
Vapotherm
This company manufactures non-invasive respiratory support devices for clinicians treating patients with chronic or acute breathing disorders in hospital settings.
Inogen
This company develops and manufactures portable oxygen concentrators for patients with chronic respiratory conditions requiring long-term supplemental oxygen therapy.
Inspire Medical Systems
This company manufactures an implantable neurostimulation device for patients with moderate to severe obstructive sleep apnea who cannot benefit from continuous positive airway pressure.
Nuvaira
Nuvaira develops a catheter-based lung denervation system to treat patients with chronic obstructive pulmonary disease by disrupting overactive airway nerves.
Inari Medical
This company develops catheter-based systems for the mechanical removal of blood clots from patients for use by healthcare professionals.
AirNexis
This clinical-stage biotechnology company develops inhaled therapies for patients with chronic obstructive pulmonary disease and other respiratory conditions.
